Skip to main content

Advertisement

Log in

The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble Biomarkers

  • Cardiac Biomarkers (CR deFilippi, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To characterize and interpret recent studies of biomarkers of cardiorenal syndrome.

Recent Findings

Recent studies have questioned the mechanisms and significance of moderate worsening renal function (WRF) in patients with acute heart failure. In the setting of successful decongestion, WRF may not predict cardiorenal morbidity. Cardiac-specific biomarkers including cardiac troponins and natriuretic peptides are highly prognostic in acute and chronic HF patients with kidney impairment, and serial changes in these markers during hospitalization are also predictive of longer-term adverse outcomes. These markers also predict new HF in patients with established chronic kidney disease (CKD). The role of kidney tubular injury markers in acute HF remains controversial, with inconsistent associations with short- and long-term cardiorenal outcomes. Many cases of WRF in acute HF are not characterized by a clear pattern of renal tubular injury.

Summary

Cardiac-specific and renal-specific biomarkers may provide mechanistic and prognostic information in cardiorenal syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J. 2009;31(6):703–11. https://doi.org/10.1093/eurheartj/ehp507.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hanberg JS, Sury K, Wilson FP, Brisco MA, Ahmad T, ter Maaten JM, et al. Reduced cardiac index is not the dominant driver of renal dysfunction in heart failure. J Am Coll Cardiol. 2016;67(19):2199–208. https://doi.org/10.1016/j.jacc.2016.02.058.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589–96. https://doi.org/10.1016/j.jacc.2008.05.068.

    Article  PubMed  PubMed Central  Google Scholar 

  4. • Fudim M, Loungani R, Doerfler SM, Coles A, Greene SJ, Cooper LB, et al. Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial. Am Heart J. 2018;204:163–73. https://doi.org/10.1016/j.ahj.2018.07.019. Inovative analysis of trial data supporting the hypothesis that increaesed central venous pressures rather than forward cardiac flow determine worsening renal function, and that successful decongestion is a major prognostic marker rather than renal function.

    Article  PubMed  Google Scholar 

  5. •• Rangaswami J, Bhalla V, JEA B, Chang TI, Costa S, Lentine KL, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139(16):e840–e78. https://doi.org/10.1161/cir.0000000000000664. Comprehensive overveiw of the cardiorenal syndromes, including classification, mechanisms, biomarkers, and therapeutics.

    Article  PubMed  Google Scholar 

  6. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47(10):1987–96. https://doi.org/10.1016/j.jacc.2005.11.084.

    Article  PubMed  Google Scholar 

  7. • Ronco C, Ronco F, McCullough PA. A call to action to develop integrated curricula in cardiorenal medicine. Blood Purif. 2017;44(4):251–9. https://doi.org/10.1159/000480318. Review and opinion on methods of defining expsoures and outcomes in cardiorenal syndromes.

    Article  PubMed  Google Scholar 

  8. deFilippi CR, Seliger SL, Maynard S, Christenson RH. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem. 2007;53(8):1511–9. https://doi.org/10.1373/clinchem.2006.084533.

    Article  CAS  PubMed  Google Scholar 

  9. Salah K, Kok WE, Eurlings LW, Bettencourt P, Pimenta JM, Metra M, et al. Competing risk of cardiac status and renal function during hospitalization for acute decompensated heart failure. JACC Heart Fail. 2015;3(10):751–61. https://doi.org/10.1016/j.jchf.2015.05.009.

    Article  PubMed  Google Scholar 

  10. Bansal N, Hyre Anderson A, Yang W, Christenson RH, deFilippi CR, Deo R, et al. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the chronic renal insufficiency cohort (CRIC) study. J Am Soc Nephrol. 2015;26(4):946–56. https://doi.org/10.1681/asn.2014010108.

    Article  CAS  PubMed  Google Scholar 

  11. Schaub JA, Coca SG, Moledina DG, Gentry M, Testani JM, Parikh CR. Amino-terminal pro-B-type natriuretic peptide for diagnosis and prognosis in patients with renal dysfunction: a systematic review and meta-analysis. JACC: Heart Failure. 2015;3(12):977–89. https://doi.org/10.1016/j.jchf.2015.07.014.

    Article  PubMed  Google Scholar 

  12. Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358(20):2117–26. https://doi.org/10.1056/NEJMoa0706824.

    Article  CAS  PubMed  Google Scholar 

  13. deFilippi C, Seliger SL, Kelley W, Duh SH, Hise M, Christenson RH, et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem. 2012;58(9):1342–51. https://doi.org/10.1373/clinchem.2012.185322.

    Article  CAS  PubMed  Google Scholar 

  14. Parikh RH, Seliger SL. deFilippi CR. Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem. 2015;48(4):247–53. https://doi.org/10.1016/j.clinbiochem.2015.01.004.

    Article  CAS  PubMed  Google Scholar 

  15. Felker GM, Mentz RJ, Teerlink JR, Voors AA, Pang PS, Ponikowski P, et al. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail. 2015;17(12):1262–70. https://doi.org/10.1002/ejhf.341.

    Article  CAS  PubMed  Google Scholar 

  16. •• Aimo A, Januzzi JL, Vergaro G, Ripoli A, Latini R, Masson S, et al. Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure. Circulation. 2018;137(3):286–97. https://doi.org/10.1161/CIRCULATIONAHA.117.031560. Large individual meta-analysis demonstrating that hs-cTnI levels are strongly prognostic in CHF in patients with renal dysfunctin.

    Article  CAS  PubMed  Google Scholar 

  17. Maisel AS, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, et al. Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study. J Am Coll Cardiol. 2016;68(13):1420–31. https://doi.org/10.1016/j.jacc.2016.06.055.

    Article  CAS  PubMed  Google Scholar 

  18. • Wettersten N, Horiuchi Y, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, et al. Short-term prognostic implications of serum and urine neutrophil gelatinase-associated lipocalin in acute heart failure: findings from the AKINESIS study. Eur J Heart Fail. 2020;22(2):251–63. https://doi.org/10.1002/ejhf.1642. Demonstrates that urinary NGAL - a widely studied urinary tubular injury biomarker - is not predictive of cardiorenal outcomes in acute heart failure.

    Article  CAS  PubMed  Google Scholar 

  19. Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Franci B, et al. Comparison of neutrophil gelatinase-associated Lipocalin versus B-type natriuretic peptide and cystatin C to predict early acute kidney injury and outcome in patients with acute heart failure. Am J Cardiol. 2015;116(1):104–11. https://doi.org/10.1016/j.amjcard.2015.03.043.

    Article  CAS  PubMed  Google Scholar 

  20. Damman K, Masson S, Hillege HL, Voors AA, van Veldhuisen DJ, Rossignol P, et al. Tubular damage and worsening renal function in chronic heart failure. JACC Heart Fail. 2013;1(5):417–24. https://doi.org/10.1016/j.jchf.2013.05.007.

    Article  PubMed  Google Scholar 

  21. •• Ahmad T, Jackson K, Rao VS, Tang WHW, Brisco-Bacik MA, Chen HH, et al. Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury. Circulation. 2018;137(19):2016–28. https://doi.org/10.1161/circulationaha.117.030112. Secondary analysis of the ROSE-AHF trial showing that changes in urinary markers of tubular injury were not correlated with changes in renal function, suggesting that most cases of worsening renal function in AHF are not characterized by severe tubular injury.

    Article  PubMed  PubMed Central  Google Scholar 

  22. • Brankovic M, Akkerhuis KM, van Boven N, Anroedh S, Constantinescu A, Caliskan K, et al. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study. Kidney Int. 2018;93(4):952–60. https://doi.org/10.1016/j.kint.2017.09.013. Longutidinal observational study suggesting that long-term individual trajectories of tubular injury markers KIM-1 and NAG predict major adverse cardiovascular outcomes in chronic HF, independent of estimated glomerular filtration rate and other risk factors.

    Article  PubMed  Google Scholar 

  23. •• Lee AK, Katz R, Jotwani V, Garimella PS, Ambrosius WT, Cheung AK, et al. Distinct dimensions of kidney health and risk of cardiovascular fisease, heart failure, and mortality. Hypertension. 2019;74(4):872–9. https://doi.org/10.1161/HYPERTENSIONAHA.119.13339. Innovative analysis of multi-dimensional urinary and blood-based renal tubular and metabolic bone biomarkers in CKD patients in SPRINT, suggesting that markers of tubular reserve and metabolic metabolism predict new onset HF.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen Seliger.

Ethics declarations

Conflict of Interest

Stephen Seliger reports grants from Roche Diagnostics, Kadmon Corporation, Palladio Biosciences, Sanofi, and Reata and personal fees from Tricida Inc. In addition, Dr. Seliger has a patent “Methods for Assessing Differential Risk for Developing Heart Failure” (Patent No 10,509,044) issued.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Cardiac Biomarkers

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seliger, S. The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble Biomarkers. Curr Cardiol Rep 22, 114 (2020). https://doi.org/10.1007/s11886-020-01360-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-020-01360-8

Keywords

Navigation